{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.12 vs. cons $1.03",
      "confidence": "HIGH"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.295B vs. cons $5.260B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic orders growth",
      "prediction": "BEAT",
      "answer": "pred ~4.0% vs. cons 2.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 organic revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.5% vs. cons 3.5% (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 adjusted EBIT margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~15.55% vs. cons 15.55% (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.90 vs. cons $4.90 (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 free cash flow",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.60B vs. cons $1.60B (FY26)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 1.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.3,
  "day5_path": "FADE",
  "day5_rationale": "The ~$1.12 vs. $1.03 EPS beat and stronger ~4.0% vs. 2.0% orders should support an initial positive reaction, but the $4.90 vs. $4.90 FY26 EPS guide leaves no explicit out-period upside; with the headline preannounced and 2H price/cost and PCS execution still required, estimate revisions should be limited and the initial move should fade.",
  "day5_confidence": "MEDIUM"
}